tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZVSA Stock Latest News

ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
Company AnnouncementsZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
2d ago
8K
ZVSA
ZyVersa Therapeutics Enters Warrant Exercise Agreement
PremiumCompany Announcements
ZyVersa Therapeutics Enters Warrant Exercise Agreement
9d ago
8K
ZVSA
ZyVersa announces warrant inducement transaction for $2M in gross proceeds
PremiumThe Fly
ZyVersa announces warrant inducement transaction for $2M in gross proceeds
10d ago
ZVSA
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
PremiumThe Fly
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
10d ago
ZVSA
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
PremiumThe Fly
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
17d ago
ZVSA
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
PremiumThe FlyZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
22d ago
ZVSA
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
Premium
Company Announcements
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
23d ago
8K
ZVSA
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
Premium
The Fly
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
23d ago
ZVSA
ZyVersa Therapeutics Stockholders Approve Key Proposals
PremiumCompany Announcements
ZyVersa Therapeutics Stockholders Approve Key Proposals
1M ago
8K
ZVSA
ZyVersa Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
ZyVersa Therapeutics Reports Q1 2025 Financial Results
1M ago
ZVSA
ZyVersa Therapeutics highlights publication of data on IC 100
PremiumThe Fly
ZyVersa Therapeutics highlights publication of data on IC 100
2M ago
ZVSA
ZyVersa Therapeutics announces developments on inflammasome inhibitors
PremiumThe Fly
ZyVersa Therapeutics announces developments on inflammasome inhibitors
2M ago
ZVSA
ZyVersa Therapeutics announces publication of data on inflammasome inhibition
PremiumThe FlyZyVersa Therapeutics announces publication of data on inflammasome inhibition
3M ago
ZVSA
ZyVersa Therapeutics CEO provides update on inflammasome ASC inhibitor IC 100
Premium
The Fly
ZyVersa Therapeutics CEO provides update on inflammasome ASC inhibitor IC 100
3M ago
ZVSA
ZyVersa Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
ZyVersa Therapeutics Reports 2024 Financial Results and Progress
3M ago
ZVSA
ZyVersa CEO issues shareholder letter on PARASOL recommendations
PremiumThe Fly
ZyVersa CEO issues shareholder letter on PARASOL recommendations
3M ago
ZVSA
ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders
PremiumThe Fly
ZyVersa Therapeutics files to sell 4.21M shares of common stock for holders
4M ago
ZVSA
ZyVersa Therapeutics reports FY24 EPS ($8.48) vs. ($1089.70) last year
PremiumThe Fly
ZyVersa Therapeutics reports FY24 EPS ($8.48) vs. ($1089.70) last year
4M ago
ZVSA
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
PremiumThe Fly
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
4M ago
ZVSA
ZyVersa Therapeutics announces publication of data on inflammasome inhibition
PremiumThe FlyZyVersa Therapeutics announces publication of data on inflammasome inhibition
4M ago
ZVSA
ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition
Premium
The Fly
ZyVersa Therapeutics highlights data on NLRP3 inflammasome inhibition
4M ago
ZVSA
ZyVersa Therapeutics prices 2.1M shares at 95c in private placement
Premium
The Fly
ZyVersa Therapeutics prices 2.1M shares at 95c in private placement
4M ago
ZVSA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >